Global Human Papillomavirus (HPV) Therapeutics Market Outlook, 2019-2023 with Allergan, Bausch Health, GlaxoSmithKline, Lee's Pharmaceutical Holdings, and Merck Sharp & Dohme Dominating - ResearchAndMarkets.com

The "Global
Human Papillomavirus (HPV) Therapeutics Market 2019-2023"
report has been added to ResearchAndMarkets.com's
offering.

The human papillomavirus (HPV) therapeutics market will register a CAGR
of nearly 9% by 2023.

Technological advances in diagnostics to drive market growth

The diagnostic methods that are currently available in the market
include Pap test, colposcopy, and HPV DNA test. Pap test is a screening
procedure for cervical cancer, in which the presence of precancerous or
cancerous cells is identified on the cervix. Colposcopy is a more
advanced technique like a Pap test, which allows the examiner to take
abnormal cell tissues from the cervix.

Advent of vaccines

The global HPV therapeutics market witnessed strong advances in terms of
prevention of diseases caused by HPV. This is primarily due to the
increasing research on developing highly advanced vaccines with a longer
half-life. Vaccines were proved to have strong efficacy toward the
prevention of various disease-causing viruses and highly effective
toward the prevention of various indications caused by HPV.

Multiple-dose schedules of vaccines

Despite the availability of vaccines for the prevention of indications
caused by HPV, the market faces a challenge from their recurring doses.
As the vaccines that are currently approved for HPV are developed for
administering through invasive methods such as subcutaneous route, the
need for multiple doses affects the patient adherence toward the
completion of the dose cycle.

Key Players

• Allergan
• Bausch Health
• GlaxoSmithKline PLC
• Lee's Pharmaceutical Holdings Limited

• Merck Sharp & Dohme Corp.

Topics Covered

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

• Market ecosystem
• Market characteristics
• Market segmentation analysis

PART 04: MARKET SIZING

• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry

PART 06: MARKET SEGMENTATION BY ROA

• Comparison by RoA
• Parenteral - Market size and forecast 2018-2023
• Topical - Market size and forecast 2018-2023
• Market opportunity by RoA

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

• Geographic comparison
• North America - Market size and forecast 2018-2023
• Europe - Market size and forecast 2018-2023
• Asia - Market size and forecast 2018-2023
• ROW - Market size and forecast 2018-2023
• Key leading countries
• Market opportunity

PART 09: DRIVERS AND CHALLENGES

PART 10: MARKET TRENDS

PART 11: VENDOR LANDSCAPE

• Overview
• Landscape disruption
• Competitive scenario

PART 12: VENDOR ANALYSIS

• Vendors covered
• Vendor classification
• Market positioning of vendors
• Allergan
• Bausch Health
• GlaxoSmithKline PLC
• Lee's Pharmaceutical Holdings Limited

• Merck Sharp & Dohme Corp.

For more information about this report visit https://www.researchandmarkets.com/research/z73lhz/global_human?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20190214005505/en/